Cargando…
Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers
Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in liver transplant recipients, but their toxicity needs to be balanced against the benefits. The choice of prevention strategy...
Autores principales: | Engelmann, Cornelius, Sterneck, Martina, Weiss, Karl Heinz, Templin, Silke, Zopf, Steffen, Denk, Gerald, Eurich, Dennis, Pratschke, Johann, Weiss, Johannes, Braun, Felix, Welker, Martin-Walter, Zimmermann, Tim, Knipper, Petra, Nierhoff, Dirk, Lorf, Thomas, Jäckel, Elmar, Hau, Hans-Michael, Tsui, Tung Yu, Perrakis, Aristoteles, Schlitt, Hans-Jürgen, Herzer, Kerstin, Tacke, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465768/ https://www.ncbi.nlm.nih.gov/pubmed/32717978 http://dx.doi.org/10.3390/jcm9082352 |
Ejemplares similares
-
Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany
por: Herzer, Kerstin, et al.
Publicado: (2020) -
Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?
por: Obed, Aiman, et al.
Publicado: (2007) -
Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients
por: Gliga, Smaranda, et al.
Publicado: (2021) -
CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016) -
Suppression of CMV Infection with Letermovir in a Kidney Transplant Patient
por: Koepf, Uta S, et al.
Publicado: (2020)